rs9206

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005100.4(AKAP12):​c.*2349A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.546 in 152,044 control chromosomes in the GnomAD database, including 24,758 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 24758 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

AKAP12
NM_005100.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.13

Publications

7 publications found
Variant links:
Genes affected
AKAP12 (HGNC:370): (A-kinase anchoring protein 12) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. The encoded protein is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells. It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction. This protein and RII PKA colocalize at the cell periphery. This protein is a cell growth-related protein. Antibodies to this protein can be produced by patients with myasthenia gravis. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005100.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKAP12
NM_005100.4
MANE Select
c.*2349A>G
3_prime_UTR
Exon 5 of 5NP_005091.2
AKAP12
NM_144497.2
c.*2349A>G
3_prime_UTR
Exon 3 of 3NP_653080.1
AKAP12
NM_001370346.1
c.*2349A>G
3_prime_UTR
Exon 3 of 3NP_001357275.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKAP12
ENST00000402676.7
TSL:5 MANE Select
c.*2349A>G
3_prime_UTR
Exon 5 of 5ENSP00000384537.2

Frequencies

GnomAD3 genomes
AF:
0.546
AC:
82952
AN:
151926
Hom.:
24751
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.301
Gnomad AMI
AF:
0.525
Gnomad AMR
AF:
0.578
Gnomad ASJ
AF:
0.614
Gnomad EAS
AF:
0.455
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.698
Gnomad MID
AF:
0.443
Gnomad NFE
AF:
0.676
Gnomad OTH
AF:
0.561
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.546
AC:
82978
AN:
152044
Hom.:
24758
Cov.:
32
AF XY:
0.544
AC XY:
40447
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.301
AC:
12483
AN:
41462
American (AMR)
AF:
0.578
AC:
8825
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.614
AC:
2132
AN:
3470
East Asian (EAS)
AF:
0.454
AC:
2347
AN:
5164
South Asian (SAS)
AF:
0.431
AC:
2078
AN:
4818
European-Finnish (FIN)
AF:
0.698
AC:
7371
AN:
10562
Middle Eastern (MID)
AF:
0.438
AC:
128
AN:
292
European-Non Finnish (NFE)
AF:
0.676
AC:
45956
AN:
67988
Other (OTH)
AF:
0.559
AC:
1180
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1733
3467
5200
6934
8667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.627
Hom.:
16008
Bravo
AF:
0.528
Asia WGS
AF:
0.427
AC:
1488
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.043
DANN
Benign
0.46
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9206; hg19: chr6-151679198; COSMIC: COSV53572409; COSMIC: COSV53572409; API